PanoramicaGraficoNotizieSchermataTrader

BVT Discount Zert TEVA 27.09.2024/  DE000VM79UU6  /

EUWAX
10/06/2024  08:52:04 Var.+0.15 Denaro11:57:37 Lettera11:57:37 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
11.73EUR +1.30% 11.75
Quantità in denaro: 4,000		 11.99
Quantità in lettera: 4,000		 Teva Pharmaceutical ... - USD 27/09/2024 Call
GlobeNewswire 12:15 Nevada Copper Files for Chapter 11 Bankruptcy Protection
TeleTrader 12:06 Health Ministry: 37,124 dead in Gaza since Oct. 7
TeleTrader 12:03 Ukraine hits Russian defense systems in Crimea
GlobeNewswire 12:00 Bitfarms Announces Adoption of Shareholder Rights Plan
GlobeNewswire 12:00 VERASTEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Verastem, Inc. on Behalf of Verastem St...
GlobeNewswire 12:00 Comstock Expanding Partnership with RenFuel
GlobeNewswire 12:00 Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Secon...
GlobeNewswire 12:00 Pulsar Announces Further Analysis Putting Topaz in the Top Tier of Global Primary Helium Projects
GlobeNewswire 12:00 The Homewood Suites Washington, D.C. Downtown Unveils a Fresh New Look
TeleTrader 11:57 Zelensky stresses peace summit's importance
TeleTrader 11:46 Russian, Egyptian FMs talk Gaza ceasefire
Newsfile Corp 11:38 Aauid Media Unveils Innovative Advertising Model: Watch Movies and Videos
TeleTrader 11:33 Noble to buy Diamond Offshore Drilling for $1.6B
TeleTrader 11:15 Kazimir: ECB to enjoy summer without hurrying on rates
GlobeNewswire 11:01 Flash News: OKX Wallet Now Supports Moonland Meta
Newsfile Corp 11:00 PlasCred Circular Innovations Inc. Announces Q1 2024 Results
Newsfile Corp 11:00 PlasCred Circular Innovations Inc. verkündet Ergebnisse für Q1 2024
GlobeNewswire 11:00 Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire 11:00 VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire 11:00 Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
TeleTrader 10:59 French far-right leader Bardella to be PM candidate
GlobeNewswire 10:47 GKN Automotive reduces direct CO2e emissions by 10.5% in 2023
TeleTrader 10:42 Hamas plea to US to pressure Israel to end war
TeleTrader 10:30 Eurozone investor confidence expands in June
Newsfile Corp 10:30 2024 Begins Drilling at Agate